Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1853058

O=C(O)C(F)(F)F.[BH4-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Trifluoroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113135966-B Bicyclic derivatives of heterocyclic glucoside and preparation method and application thereof 华润双鹤药业股份有限公司 2022-12-16 CN claimed
CN-113135966-A Bicyclic derivatives of heterocyclic glucoside and preparation method and application thereof 华润双鹤药业股份有限公司 2021-07-20 CN claimed
CN-113004157-A Preparation method of ambroxol hydrochloride 康普药业股份有限公司 2021-06-22 CN claimed
CN-112759623-A Synthetic method of deoxycholic acid 中山百灵生物技术股份有限公司 2021-05-07 CN claimed
US-9765044-B2 Synthesis of novel ionic liquids from lignin-derived compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-09-19 US claimed
US-20160031843-A1 SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS UNITED STATES DEPARTMENT OF ENERGY 2016-02-04 US claimed
CN-105061230-A Method for preparing dapoxetine hydrochloride KAMP PHARMACEUTICALS CO LTD 2015-11-18 CN claimed
CN-102702196-B Method for synthesizing 3-methyl-7-diazaindene NANJING YAOSHI PHARMACEUTICAL RES DEV CO LTD 2015-01-14 CN claimed
WO-2014172042-A1 SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS SANDIA CORPORATION (US) 2014-10-23 WO claimed
CN-103304466-A Synthetic method of 3-alkyl-substituted indole compound CHIMICA LAB CO LTD 2013-09-18 CN claimed
CN-102249937-A Preparation method of 1-(S)-4, 5-dimethyamino-1-methylaminomethyl-benzocyclobutane SHANGHAI JINGXIN BIOLOG MEDICAL CO LTD 2011-11-23 CN claimed
CN-102086202-A Method for quickly preparing cis-octahydropyrrolo[3,2-b]pyrrole WUXI APP INC 2011-06-08 CN claimed
CN-113004157-A Preparation method of ambroxol hydrochloride 康普药业股份有限公司 2021-06-22 CN disclosed
CN-112759623-A Synthetic method of deoxycholic acid 中山百灵生物技术股份有限公司 2021-05-07 CN disclosed
CN-112759623-A Synthetic method of deoxycholic acid 中山百灵生物技术股份有限公司 2021-05-07 CN disclosed
CN-110551055-B Preparation method of 3- (4-chlorobutyl) -5-cyanoindole 新发药业有限公司 2021-01-22 CN disclosed
US-20020055505-A1 SULTAM AND SULTONE DERIVED OXAZOLIDINONES ANDERSON DAVID JOHN (US) 2002-05-09 US disclosed
US-6348459-B1 DRUGS AND ANTIBIOTIC AGENTS. PHARMACIA AND UPJOHN COMPANY 2002-02-19 US disclosed
WO-2001032657-A1 ANTIBIOTIC SULTAM AND SULTONE DERIVED OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 2001-05-10 WO disclosed
US-4935505-A NUCLEOSIDES; ADENOSINE DEAMINASE INHIBITORS TOWNSEND LEROY B (US) 1990-06-19 US disclosed